Private Equity Tied to 15% Rise in Healthcare Spending

By VirentaNews Staff — May 26, 2026

Private equity ownership in U.S. healthcare has surged over the past two decades, now encompassing hospitals, dialysis centers, mental health clinics, and physician practices—and a new review published in Annals of Internal Medicine links this trend to increased costs and deteriorating patient care. The paper, synthesizing over 100 studies, finds that private equity-backed facilities often prioritize financial returns over clinical outcomes, leading to higher prices, staff reductions, and in some cases, increased mortality. With more than $200 billion invested in healthcare since 2000, the authors argue that current regulatory frameworks are insufficient to protect patients, calling for stricter antitrust enforcement, transparency mandates, and policy interventions to safeguard the integrity of care delivery.

Private Equity’s Expanding Footprint in Healthcare

Private equity firms have increasingly targeted the U.S. healthcare sector, attracted by its size, fragmentation, and potential for operational efficiencies. According to the analysis, more than 1,000 healthcare facilities have come under private equity ownership since 2010, including specialty hospitals, outpatient surgery centers, and behavioral health providers. The model typically involves acquiring a facility, cutting costs—often through staffing reductions or supply chain renegotiations—and then reselling it within three to seven years for profit. While some investments yield short-term financial gains, the review highlights consistent patterns of rising prices: one study cited found that private equity-owned dialysis centers charged 15% more than nonprofit counterparts. Other investigations revealed declines in nurse staffing, increased emergency transfers, and even higher patient mortality rates in acquired nursing homes.

The Rise of Financial Engineering in Medicine

The infiltration of private equity into healthcare is rooted in broader trends of financialization that began in the 1980s, when Wall Street increasingly viewed hospitals and clinics as revenue-generating assets. But the pace accelerated after the 2008 financial crisis, as low interest rates and abundant capital pushed investors toward stable sectors like healthcare. Regulatory loopholes have enabled this expansion: unlike public companies, private equity firms are not required to disclose ownership structures or financial performance to the public. The study notes that many acquisitions occur through complex holding companies, obscuring accountability. Moreover, existing antitrust laws have not kept pace with consolidation strategies that allow firms to amass networks of clinics across specialties, reducing competition and inflating prices.

Key Players and Their Incentives

The private equity firms driving these acquisitions—such as KKR, Blackstone, and Leonard Green & Partners—operate under fiduciary duty to maximize returns for investors, not patient outcomes. Executives are often compensated based on short-term financial metrics, creating strong incentives to extract value quickly. In some cases, this has led to aggressive cost-cutting, asset stripping, or financial maneuvers like dividend recapitalizations, where companies take on debt to pay investors, weakening their financial resilience. Meanwhile, physicians and hospital administrators caught in these transitions report feeling pressured to increase patient volume and reduce time per visit. Frontline staff describe a shift in culture—from mission-driven care to profit-centered operations—though some acknowledge that targeted investments in technology or infrastructure can benefit certain facilities, at least initially.

Impact on Patients and the Healthcare System

The consequences of private equity involvement are most acutely felt by vulnerable populations, including the elderly, low-income patients, and those with chronic conditions. For example, the review highlights a 2023 JAMA Internal Medicine study showing that nursing homes acquired by private equity firms experienced a 10% increase in five-star rating downgrades and higher rates of deficiencies in care. Similarly, mental health clinics under private equity ownership were more likely to discharge patients prematurely to optimize billing cycles. These trends threaten not only individual outcomes but also the broader healthcare ecosystem, as cost-shifting and reduced access strain public hospitals and safety-net providers. Insurers and employers also face higher premiums, ultimately passing costs to consumers.

The Bigger Picture

This growing scrutiny of private equity in healthcare reflects a larger reckoning with the role of finance in essential public services. As healthcare continues to account for nearly one-fifth of the U.S. economy, the tension between profitability and public good becomes increasingly untenable. Other countries with universal systems tightly restrict private ownership of core health services, but the U.S. remains an outlier in allowing such deep financial integration. The Annals paper joins a chorus of voices—from the American Medical Association to the Government Accountability Office—calling for policy reforms. Without intervention, experts warn that the financialization of care could erode trust in the medical system and deepen inequities.

What comes next may hinge on federal and state regulatory action. Proposals under discussion include mandating public disclosure of private equity healthcare ownership, strengthening the Federal Trade Commission’s authority to block harmful consolidations, and revising Medicare reimbursement rules to disincentivize private equity takeovers. Lawmakers in several states have introduced bills to increase oversight, and the Biden administration has signaled interest in curbing corporate consolidation in healthcare. As evidence mounts, the debate is no longer whether private equity affects care—but how aggressively policymakers will move to protect it.

Source: Acpjournals